Top Markets
Coin of the day
Avisa Diagnostics Inc. Avisa Diagnostics Inc.

Avisa Diagnostics Inc.

AVBT
Rang in Aktien #40597
Avisa Diagnostics Inc., a clinical-stage medical device company based in Santa... Avisa Diagnostics Inc., a clinical-stage medical device company based in Santa Fe, New Mexico, is dedicated to developing the Avisa BreathTest. This innovative drug/device biomarker technology platform is designed for the ultra-rapid identification of virulent bacterial pathogens and the subsequent monitoring of bacterial load. The system works by analyzing a patient's breath after they have inhaled or ingested Avisa's proprietary drug substrates. The company has already established clinical proof-of-concept through trials in conditions such as cystic fibrosis, tuberculosis, and community-acquired pneumonia, and is now concentrating on pivotal trials for Post-COVID-19 bronchiectasis and ventilator-associated pneumonia.
Aktienkurs
$0.0333321
Zuletzt synchronisiert: 2023-05-23
Marktkapitalisierung
$114.40K
Veränderung (1 Tag)
-0.04%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Avisa Diagnostics Inc. (AVBT)

Kategorie

Kursverlauf für Avisa Diagnostics Inc. (AVBT)
Höchster Schlusskurs: $0.03 am 2023-05-01

Niedrigster Schlusskurs: $1.28K am 2010-02-01
Kursverlauf der Aktie von Avisa Diagnostics Inc. von 2010 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2023 0.82%
2022 -6.22%
2021 -78.93%
2020 72.80%
2019 -92.36%
2018 -65.35%
2017 112.29%
2016 -36.80%
2015 -15.77%
2014 -55.01%
2013 -75.00%
2012 -90.82%
2011 -65.31%
2010 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$111.44 -13.88%
US
$341.38 -9.91%
US
$90.60 -2.49%
IE
$51.77 -49.49%
US
$92.54 19.12%
US